Dr. Karan Lal recently discussed his experience treating Epidermolysis Bullosa (EB), a rare genetic skin disorder.
The American Academy of Dermatology Publishes Updated Guidelines for the Care and Management of Atopic Dermatitis
The American Academy of Dermatology has published updated guidelines for the care and management of atopic dermatitis.
Arcutis Biotherapeutics Submits Supplemental New Drug Application for Roflumilast Cream for the Treatment of Plaque Psoriasis in Children Down to 2 Years of Age
Arcutis Biotherapeutics has submitted a Supplemental New Drug Application to the FDA for the expanded indication of Zoryve cream for plaque psoriasis.
Patricia K. Farris, MD recently shared some insight into the topics she will be covering at South Beach Symposium 2023.
The fast-track designation is for the clinical study of the plasmid DNA vaccine ITI-3000 in patients with Merkel cell carcinoma.
Accure Acne, Inc. announced the FDA had cleared their Accure Laser™ System for treating mild-to-severe inflammatory acne vulgaris.
Results from a nonrandomized clinical trial suggest that apremilast (Otezla), may have cardiometabolic health benefits for patients with psoriasis.
The FDA approved ellacor System uses micro-coring technology (MCT) to treat facial wrinkles and tightening.
South Beach Symposium has been a cornerstone in medical and aesthetic dermatologic education for 20 years.
Dermatologists have seen an increase of acne in adult females and ponder the best treatment options available for their patients.